December 2, 2009
ReSearch Pharmaceutical Services, Inc. (RPS), a next generation contract research organization (CRO) and provider of integrated clinical development outsourcing solutions, has announced the completion of its global platform to provide integrated CRO services across four continents.
In a release, the Company noted that it has positioned itself to capitalize on the growth of global clinical trials. PharmaVoice reported that up to 65 percent of FDA-regulated clinical trials in the next three years will be conducted outside of the United States, with Asia as one of the primary regions.
In creating its global platform, RPS said that it recently incorporated its subsidiaries in more than 30 countries throughout the world, including Japan, Korea, Malaysia, Philippines, Singapore, Taiwan, and Thailand. The company also recently completed its acquisition of Paramax International (Beijing), Inc., a specialized contract research organization operating in China.
“Asia — and China in particular — is critically important to our clients,” noted Dan Perlman, Chairman and CEO of RPS. “Our acquisition of Paramax, along with the expansion of our unique service offerings throughout Asia provides deep local presence, which combined with our world-class platform enables us to serve our clients in a highly efficient manner. We have already begun to see significant revenue growth throughout the region.”
In the past 12 months, RPS added that it has also strengthened its platform and local expertise in Europe through strategic acquisitions of CROs in France, Spain, and Germany.
“RPS offers comprehensive and customized solutions for the pharmaceutical industry,” said Peter Yu, Managing Partner of Cartesian Capital Group and an RPS Board member. “We see an extraordinary need and demand for RPS’ offering around the world, especially as the outsourcing of clinical trials is growing. The Paramax acquisition and the recent global expansion of its platform will ensure that RPS clients receive the highest quality integrated CRO services wherever they need it.”
(Comments on this story may be sent to [email protected])
Photo: Pacific Northwest National Laboratories researchers by U.S. Department of Energy, CC0 1.0, via rawpixel